MindChild files FDA application for fetal heart monitor

MindChild Medical Inc., a North Andover medical device company, said it has completed the filing of a Pre-Marketing Notification Application with the Food and Drug Administration for a non-invasive fetal heart monitor.

In a press release, the company said it expects feedback from the FDA during the next quarter and anticipates entering the US market with its Meridian fetal heart monitor following FDA pre-market clearance.


Last year, there were about 4.1 million births in the United States, and 85 percent of them required fetal monitoring during labor and delivery, MindChild Medical said.

According to the company, its Meridian product candidate is safer and more effective than fetal heart monitors currently on the market.

Chris Reidy can be reached at
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of